317 related articles for article (PubMed ID: 35757733)
1. Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System.
Stevenson MM; Valanparambil RM; Tam M
Front Immunol; 2022; 13():874308. PubMed ID: 35757733
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.
Glover A; Zhang Z; Shannon-Lowe C
Front Immunol; 2023; 14():1161848. PubMed ID: 37033972
[TBL] [Abstract][Full Text] [Related]
3. Chronic helminth infections induce immunomodulation: consequences and mechanisms.
van Riet E; Hartgers FC; Yazdanbakhsh M
Immunobiology; 2007; 212(6):475-90. PubMed ID: 17544832
[TBL] [Abstract][Full Text] [Related]
4. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals.
Beliakova-Bethell N; Maruthai K; Xu R; Salvador LCM; Garg A
Front Immunol; 2022; 13():894543. PubMed ID: 35812392
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer.
Metzger P; Kirchleitner SV; Kluge M; Koenig LM; Hörth C; Rambuscheck CA; Böhmer D; Ahlfeld J; Kobold S; Friedel CC; Endres S; Schnurr M; Duewell P
J Immunother Cancer; 2019 Nov; 7(1):288. PubMed ID: 31694706
[TBL] [Abstract][Full Text] [Related]
6. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
Front Immunol; 2021; 12():625712. PubMed ID: 33815377
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells and vaccination against pathogens.
Prochetto E; Borgna E; Jiménez-Cortegana C; Sánchez-Margalet V; Cabrera G
Front Cell Infect Microbiol; 2022; 12():1003781. PubMed ID: 36250061
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils.
Goldmann O; Beineke A; Medina E
J Infect Dis; 2017 Dec; 216(11):1444-1451. PubMed ID: 29029332
[TBL] [Abstract][Full Text] [Related]
9. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
Front Immunol; 2021; 12():803014. PubMed ID: 35116033
[TBL] [Abstract][Full Text] [Related]
10. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
Karin N
Front Immunol; 2020; 11():557586. PubMed ID: 33193327
[TBL] [Abstract][Full Text] [Related]
11. CD205
Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
[TBL] [Abstract][Full Text] [Related]
12. Presence of Infected Gr-1
Abdissa K; Nerlich A; Beineke A; Ruangkiattikul N; Pawar V; Heise U; Janze N; Falk C; Bruder D; Schleicher U; Bogdan C; Weiss S; Goethe R
Front Immunol; 2018; 9():2317. PubMed ID: 30386330
[TBL] [Abstract][Full Text] [Related]
13. Regulation of allergy and autoimmunity in helminth infection.
Wilson MS; Maizels RM
Clin Rev Allergy Immunol; 2004 Feb; 26(1):35-50. PubMed ID: 14755074
[TBL] [Abstract][Full Text] [Related]
14. The role of myeloid-derived suppressor cells in immune ontogeny.
Gantt S; Gervassi A; Jaspan H; Horton H
Front Immunol; 2014; 5():387. PubMed ID: 25165466
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
Tamadaho RSE; Hoerauf A; Layland LE
Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers.
Fan R; De Beule N; Maes A; De Bruyne E; Menu E; Vanderkerken K; Maes K; Breckpot K; De Veirman K
Front Immunol; 2022; 13():1016059. PubMed ID: 36304465
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.
Magcwebeba T; Dorhoi A; du Plessis N
Front Immunol; 2019; 10():917. PubMed ID: 31114578
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
[TBL] [Abstract][Full Text] [Related]
19. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
[TBL] [Abstract][Full Text] [Related]
20. Glycan gimmickry by parasitic helminths: a strategy for modulating the host immune response?
van Die I; Cummings RD
Glycobiology; 2010 Jan; 20(1):2-12. PubMed ID: 19748975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
